Opportunity Information: Apply for CDC RFA GH15 1564
Apply for CDC RFA GH15 1564
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Increasing Access to HIV Prevention, Care and Treatment Services for Key Populations in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Aug 21, 2014 and posted on Aug 21, 2014.
- Applicants must submit their applications by Oct 5, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $4,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Small, minority, and women owned businesses All Other eligible organizations
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through PEPFAR, released this funding opportunity to expand and strengthen HIV prevention, care, and treatment services for key populations (KP) and other vulnerable groups in Mozambique, particularly in provinces where HIV risk is intensified by local economic and social conditions. The FOA focuses on areas with high HIV prevalence that are also experiencing rapid development tied to multinational industry, transport corridors, and growing tourism. These settings often bring high mobility and a transient male workforce, which can increase the likelihood of commercial sex work and transactional sex and, in turn, drive new HIV infections. The overall purpose is to reduce HIV transmission and improve health outcomes by making prevention and clinical services easier to access and more responsive to the realities faced by KP and other priority populations.
The program is designed around a combination prevention model, meaning applicants are expected to integrate behavioral, biomedical, and structural interventions rather than rely on a single approach. On the behavioral side, the FOA emphasizes improving knowledge of HIV and sexually transmitted infections (STIs), reducing sexual risk behaviors, and strengthening demand for HIV testing and counseling (HTC). On the biomedical side, the announcement highlights established, evidence-based interventions such as voluntary medical male circumcision (VMMC), along with the expectation that implementers consider additional or emerging tools where appropriate, including pre-exposure prophylaxis (PrEP), and strong STI diagnosis and treatment components. On the structural side, the work should address barriers that prevent KP and other vulnerable populations from using services consistently, such as stigma, discrimination, mobility, and limited availability of KP-friendly service delivery options. The FOA frames these pieces as a comprehensive prevention package that is meant to be coordinated, targeted, and measurable.
A central expectation is that the funded program will increase uptake and coverage across the HIV service continuum, not just expand outreach. In practical terms, this includes generating demand for HTC among KP and orphans and vulnerable populations (the FOA references OVC/OVP terminology), linking people who test positive to appropriate care, and supporting access to universal coverage of HIV treatment for all eligible people living with HIV (PLHIV) within these populations. The announcement also stresses the importance of improving access to related health services beyond HIV alone, specifically calling out STI and tuberculosis (TB) services in addition to other healthcare services. That reflects a broader public health approach: KP-centered programs are expected to connect clients to the full set of services that commonly intersect with HIV risk and HIV outcomes, rather than operating as isolated testing campaigns.
The FOA places strong emphasis on building a robust "reach, test, treat, retain" cascade tailored to KP and other priority groups. That means the work should be organized so that people can be identified and engaged (reach), encouraged and enabled to test (test), started on appropriate prevention or treatment services based on results (treat, including treatment for those living with HIV and prevention options for those who are HIV-negative), and then supported to remain in care and adhere over time (retain). The cascade language signals that performance is expected to be tracked end-to-end, with attention to drop-offs between steps and strategies to reduce loss to follow-up, which is often a major challenge in highly mobile communities and among populations facing stigma or legal and social barriers.
From an administrative standpoint, this was a discretionary funding opportunity offered as a cooperative agreement, indicating CDC planned substantial involvement in program oversight and collaboration during implementation. The opportunity number is CDC RFA GH15-1564 under CFDA 93.067 (Global AIDS). CDC anticipated making one award, with an award ceiling of $4,500,000. The opportunity did not require cost sharing or matching. It was originally posted on August 21, 2014, with a closing date of October 5, 2014, and an archive date of November 4, 2014.
Eligibility was intentionally broad and included a wide range of government and non-government entities. Eligible applicants included national ministries of health and state/local governments (including U.S. territories and certain affiliated jurisdictions), tribal governments and tribally designated organizations, nonprofit organizations with or without 501(c)(3) status, community-based and faith-based organizations, colleges and universities, hospitals, research institutions performing non-research activities, and for-profit organizations (other than small businesses), including small, minority-, and women-owned businesses, plus other eligible organizations as described in the full announcement. In short, CDC structured eligibility to allow experienced implementers across sectors to compete, especially organizations capable of operating in complex field settings and delivering integrated prevention and clinical programming for marginalized and high-risk populations.
Overall, the FOA is best understood as a targeted scale-up effort: it aims to reduce HIV risk and improve treatment outcomes in Mozambican hotspots where economic growth and mobility increase vulnerability, by funding one implementer to deliver a coordinated package of prevention, testing, linkage, treatment, and retention activities tailored to KP and other vulnerable groups, while also strengthening access to related STI and TB services and using evidence-based interventions such as VMMC alongside additional tools like PrEP where appropriate.
Frequently Asked Questions (FAQs)
What is this funding opportunity about?
This CDC funding opportunity (through PEPFAR) supports expanding and strengthening HIV prevention, care, and treatment services for key populations (KP) and other vulnerable groups in Mozambique, especially in provinces where local economic and social conditions intensify HIV risk.
Who is the funder and what is the funding mechanism?
The funder is the Centers for Disease Control and Prevention (CDC) through PEPFAR. The award mechanism is a discretionary cooperative agreement, meaning CDC expected substantial involvement in oversight and collaboration during implementation.
What is the opportunity number and CFDA listing?
The opportunity number is CDC RFA GH15-1564. The CFDA is 93.067 (Global AIDS).
How many awards did CDC anticipate making?
CDC anticipated making one award.
What is the maximum award amount?
The award ceiling was $4,500,000.
Is cost sharing or matching required?
No. The opportunity did not require cost sharing or matching.
When was the opportunity posted and when did it close?
It was originally posted on August 21, 2014. The closing date was October 5, 2014. The archive date was November 4, 2014.
Where is the work expected to focus geographically?
The work targets Mozambique, with particular attention to provinces with high HIV prevalence and rapid development tied to multinational industry, transport corridors, and growing tourism.
Why do industry, transport corridors, and tourism matter for HIV risk in this FOA?
These settings often involve high mobility and a transient male workforce, which can increase commercial sex work and transactional sex, contributing to new HIV infections. The FOA prioritizes these hotspots because local conditions can amplify risk quickly.
Who are the priority populations for this program?
The focus is on key populations (KP) and other vulnerable groups, including references to orphans and vulnerable populations (OVC/OVP terminology) and people living with HIV (PLHIV) within these populations.
What is the overall purpose of the program?
The program aims to reduce HIV transmission and improve health outcomes by making prevention and clinical services easier to access and more responsive to the realities faced by KP and other priority populations.
What does "combination prevention" mean in this FOA?
Applicants are expected to integrate behavioral, biomedical, and structural interventions into one coordinated approach rather than relying on a single strategy.
What behavioral interventions are emphasized?
The FOA emphasizes improving knowledge of HIV and sexually transmitted infections (STIs), reducing sexual risk behaviors, and strengthening demand for HIV testing and counseling (HTC).
What biomedical interventions are highlighted?
The FOA highlights evidence-based interventions such as voluntary medical male circumcision (VMMC). It also expects implementers to consider additional or emerging tools where appropriate, including pre-exposure prophylaxis (PrEP), along with strong STI diagnosis and treatment components.
What structural barriers should the program address?
The work should address barriers that reduce consistent service use, including stigma, discrimination, mobility, and limited availability of KP-friendly service delivery options.
Does the FOA prioritize outreach alone or the full service continuum?
The FOA emphasizes increasing uptake and coverage across the HIV service continuum, not just expanding outreach. This includes demand generation for HTC, linkage to care for those testing positive, and support for access to universal coverage of HIV treatment for all eligible PLHIV within the priority populations.
What is meant by the "reach, test, treat, retain" cascade?
The FOA expects a tailored cascade for KP and other priority groups: identifying and engaging people (reach), enabling them to test (test), initiating appropriate prevention or treatment services based on results (treat), and supporting ongoing engagement and adherence over time (retain).
How is performance expected to be tracked?
The cascade framing implies end-to-end performance tracking, with attention to drop-offs between steps and strategies to reduce loss to follow-up, especially in highly mobile communities and among populations facing stigma or legal and social barriers.
Are services beyond HIV included in the expected scope?
Yes. The FOA stresses improving access to related health services beyond HIV, specifically calling out STI and tuberculosis (TB) services, in addition to other healthcare services.
What is the expected relationship between HIV services and STI/TB services?
The FOA reflects a broader public health approach: KP-centered programs are expected to connect clients to services that intersect with HIV risk and outcomes (not operate as isolated testing campaigns). This includes linking or integrating HIV work with STI diagnosis/treatment and TB services.
What kinds of organizations were eligible to apply?
Eligibility was broad and included government and non-government entities such as national ministries of health and state/local governments (including U.S. territories and certain affiliated jurisdictions), tribal governments and tribally designated organizations, nonprofits with or without 501(c)(3) status, community-based and faith-based organizations, colleges and universities, hospitals, research institutions performing non-research activities, and for-profit organizations (other than small businesses), including small, minority-, and women-owned businesses, plus other eligible organizations as described in the full announcement.
Is this opportunity mainly a scale-up effort or a research program?
Based on the description, it is a targeted scale-up effort focused on delivering coordinated prevention and clinical programming in high-risk Mozambican hotspots, rather than a stand-alone research initiative.
What is the program expected to deliver in practical terms?
The FOA describes a coordinated package that generates demand for HTC, links HIV-positive individuals to care, supports universal treatment access for all eligible PLHIV within the priority groups, strengthens retention and adherence, and improves access to STI and TB services, using evidence-based tools such as VMMC and considering PrEP where appropriate.
Why does the FOA emphasize KP-friendly service delivery options?
The FOA notes that stigma, discrimination, mobility, and limited KP-friendly options can prevent consistent service use. Addressing these barriers is part of the structural component of combination prevention and is necessary to improve continuity across the cascade.
What does the cooperative agreement structure imply for implementation?
It indicates CDC planned substantial involvement in program oversight and collaboration during implementation, rather than a hands-off relationship.
What is the simplest way to summarize the FOA?
It funds one implementer to scale up an integrated, measurable HIV prevention and treatment continuum for KP and other vulnerable groups in Mozambique hotspots shaped by rapid economic development and mobility, while also strengthening access to STI and TB services and using evidence-based interventions like VMMC with consideration of tools like PrEP.
Browse more opportunities from the same category: Health
Next opportunity: 2014 DRAFT IFRP PRODUCT RFA DRAFT
Previous opportunity: Centers Without Walls for Collaborative Research in the Epilepsies Developing Disease Modifying or Prevention Therapies (U54)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1564
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1564) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Forum for State and Territorial Chief Executives (National Forum) Apply for HRSA 15 040 Funding Number: HRSA 15 040 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Voluntary Medical Male Circumcision as part of the National Program and the Combination Prevention Project in Botswana under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH15 1506 Funding Number: CDC RFA GH15 1506 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| National Indian Health Outreach and Education Apply for HHS 2014 IHS NIHOE 0001 Funding Number: HHS 2014 IHS NIHOE 0001 Agency: Indian Health Service Category: Health Funding Amount: $766,000 |
| National Indian Health Outreach and Education III Apply for HHS 2014 IHS NIHOE 0003 Funding Number: HHS 2014 IHS NIHOE 0003 Agency: Indian Health Service Category: Health Funding Amount: $600,000 |
| Interdisciplinary Research to Understand the Vascular Contributions to Alzheimers Disease (R01) Apply for RFA AG 15 010 Funding Number: RFA AG 15 010 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Comprehensive Approaches to Strengthening the Health System and HIV Response in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1556 Funding Number: CDC RFA GH15 1556 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $22,000,000 |
| Strengthening Mozambican Capacity in Health Information Systems in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1565 Funding Number: CDC RFA GH15 1565 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Public Private Partnerships in PEPFAR Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1539 Funding Number: CDC RFA GH15 1539 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $20,000,000 |
| Improving HIV/STI/TB Prevention, Treatment and Care Services for Mobile Populations in the Dominican Republic under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1517 Funding Number: CDC RFA GH15 1517 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Capacity Building through Training and Mentoring for Treatment, Care and Support, Including PMTCT, TB/HIV, Laboratory, Informatics, and Cervical Cancer in Botswana under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1504 Funding Number: CDC RFA GH15 1504 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,787,357 |
| Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services in Manzini Region, and Provide Central Level Technical Assistance to the National Tuberculosis Apply for CDC RFA GH15 1583 Funding Number: CDC RFA GH15 1583 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,200,000 |
| Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region, Apply for CDC RFA GH15 1582 Funding Number: CDC RFA GH15 1582 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,200,000 |
| Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1581 Funding Number: CDC RFA GH15 1581 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,100,000 |
| Implementing an Electronic Monitoring and Reporting System in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1569 Funding Number: CDC RFA GH15 1569 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $310,000 |
| Monitoring and Evaluation Technical Support (METS) to Strengthen Monitoring and Evaluation, Disease Surveillance and the Capabilities of District Health Teams in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1611 Funding Number: CDC RFA GH15 1611 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,400,000 |
| Strengthening Regional and Community Health Systems through Support for Field Epidemiology in Tanzania under the Presidens Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1585 Funding Number: CDC RFA GH15 1585 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Technical Assistance for Strengthening National Laboratory Systems in Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1593 Funding Number: CDC RFA GH15 1593 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Strengthening the Capacity to Scale up HIV Prevention, Care and Treatment Programs in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1572 Funding Number: CDC RFA GH15 1572 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,800,000 |
| Support to Increasing Access to Voluntary Medical Male Circumcision (VMMC) Services in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1555 Funding Number: CDC RFA GH15 1555 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Increase Access to Comprehensive HIV/AIDS Prevention, Care and Treatment Services in the Democratic Republic of Congo under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1521 Funding Number: CDC RFA GH15 1521 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1564", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.